DrugPatentWatch Database Preview
Drugs in Development Information for Bevasiranib
Drug Development Status for Bevasiranib: Sponsors, patents, clinical trial progress
Bevasiranib is an investigational drug.
There have been 5 clinical trials for Bevasiranib.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Macular Degeneration, Choroidal Neovascularization, and Macular Edema. The leading clinical trial sponsors are OPKO Health, Inc. and [disabled in preview].
There are four US patents protecting this investigational drug and fifty-one international patents.
Summary for Bevasiranib
| US Patents | 4 |
| International Patents | 51 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-11-01) |
| Vendors | 0 |
Recent Clinical Trials for Bevasiranib
| Title | Sponsor | Phase |
|---|---|---|
| Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) | OPKO Health, Inc. | Phase 3 |
| Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD | OPKO Health, Inc. | Phase 3 |
| Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema | OPKO Health, Inc. | Phase 2 |
Clinical Trial Summary for Bevasiranib
Top disease conditions for Bevasiranib
Top clinical trial sponsors for Bevasiranib
US Patents for Bevasiranib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bevasiranib | Start Trial | Recombinant vectors | Tocagen Inc. (San Diego, CA) | Start Trial |
| Bevasiranib | Start Trial | Reverse thermal gels and uses therefor | University of Pittsburgh--Of the Commonwealth System of Higher Education (Pittsburgh, PA) | Start Trial |
| Bevasiranib | Start Trial | Reverse thermal gels and uses therefor | University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh, PA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bevasiranib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bevasiranib | Australia | 2009303690 | 2028-09-26 | Start Trial |
| Bevasiranib | Brazil | PI0919113 | 2028-09-26 | Start Trial |
| Bevasiranib | Canada | 2738472 | 2028-09-26 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
